Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.2499 EUR
−4.94 M EUR
0.00 EUR
18.22 M
About Herantis Pharma Plc
Sector
Industry
CEO
Antti Vuolanto
Website
Headquarters
Espoo
Founded
2008
ISIN
FI4000087861
Herantis Pharma Oyj engages in the research and development of biopharmaceutical products. It offers medicinal products such as Cis-UCA eye drops for dry eye, CDNF for Parkinson's disease, Lymfactin for secondary lymphedema, Cis-UCA emulsion cream for atopic dermatitis, and CDNF for amyotrophic lateral sclerosis (ALS). The company was founded by Eero Hemminki Castren, Henri Juhani Huttunen, Heikki Rauvala, and Mart Saarma in 2008 and is headquartered in Espoo, Finland.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of A1158V is 1.9300 EUR — it has increased by 11.24% in the past 24 hours. Watch Herantis Pharma Plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LS exchange Herantis Pharma Plc stocks are traded under the ticker A1158V.
We've gathered analysts' opinions on Herantis Pharma Plc future price: according to them, A1158V price has a max estimate of 2.10 EUR and a min estimate of 2.10 EUR. Watch A1158V chart and read a more detailed Herantis Pharma Plc stock forecast: see what analysts think of Herantis Pharma Plc and suggest that you do with its stocks.
A1158V reached its all-time high on Aug 19, 2025 with the price of 1.9300 EUR, and its all-time low was 1.3050 EUR and was reached on Jun 30, 2025. View more price dynamics on A1158V chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
A1158V stock is 10.10% volatile and has beta coefficient of −0.27. Track Herantis Pharma Plc stock price on the chart and check out the list of the most volatile stocks — is Herantis Pharma Plc there?
Today Herantis Pharma Plc has the market capitalization of 43.61 M, it has decreased by −2.06% over the last week.
Yes, you can track Herantis Pharma Plc financials in yearly and quarterly reports right on TradingView.
Herantis Pharma Plc is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our Earnings Calendar.
Herantis Pharma Plc revenue for the last half-year amounts to 5.00 K EUR, despite the estimated figure of 5.00 K EUR. In the next half-year revenue is expected to reach 5.00 K EUR.
A1158V net income for the last half-year is −3.20 M EUR, while the previous report showed −2.25 M EUR of net income which accounts for −42.08% change. Track more Herantis Pharma Plc financial stats to get the full picture.
No, A1158V doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 6, 2025, the company has 11 employees. See our rating of the largest employees — is Herantis Pharma Plc on this list?
Like other stocks, A1158V shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Herantis Pharma Plc stock right from TradingView charts — choose your broker and connect to your account.